Do analysts recommend CRVL or CHE?

Chemed has a consensus target price of $501.50, indicating a potential upside of 14.80%. Given Chemed's stronger consensus rating and higher possible upside, analysts plainly believe Chemed is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Chemed 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has stronger earnings & valuation, CRVL or CHE?

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.10 $110.34M $2.14 27.35 Chemed $2.54B 2.28 $265.24M $18.35 23.81

Is CRVL or CHE more profitable?

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.23%. CorVel's return on equity of 29.92% beat Chemed's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.51% 29.92% 17.68% Chemed 10.23% 27.18% 17.38%

Does the media refer more to CRVL or CHE?

In the previous week, CorVel and CorVel both had 4 articles in the media. Chemed's average media sentiment score of 1.21 beat CorVel's score of 0.46 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemed 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MD or CRVL?

In the previous week, CorVel had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Pediatrix Medical Group. CorVel's average media sentiment score of 0.46 beat Pediatrix Medical Group's score of 0.00 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AMN or CRVL?

AMN Healthcare Services presently has a consensus target price of $25.29, suggesting a potential downside of 18.47%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMN Healthcare Services 2 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.22 CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor AMN or CRVL?

In the previous week, AMN Healthcare Services had 9 more articles in the media than CorVel. MarketBeat recorded 13 mentions for AMN Healthcare Services and 4 mentions for CorVel. CorVel's average media sentiment score of 0.46 beat AMN Healthcare Services' score of 0.42 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CCRN or CRVL?

In the previous week, CorVel had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Cross Country Healthcare. CorVel's average media sentiment score of 0.46 beat Cross Country Healthcare's score of 0.00 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer DGX or CRVL?

Quest Diagnostics currently has a consensus price target of $216.58, suggesting a potential upside of 11.19%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities analysts clearly believe Quest Diagnostics is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, DGX or CRVL?

Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quest Diagnostics $11.04B 1.95 $992M $9.05 21.52 CorVel $958.53M 3.10 $110.34M $2.14 27.35

Is DGX or CRVL more profitable?

CorVel has a net margin of 11.51% compared to Quest Diagnostics' net margin of 9.07%. CorVel's return on equity of 29.92% beat Quest Diagnostics' return on equity. Company Net Margins Return on Equity Return on Assets Quest Diagnostics 9.07% 15.60% 7.06% CorVel 11.51% 29.92% 17.68%

Does the media prefer DGX or CRVL?

In the previous week, Quest Diagnostics had 10 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Quest Diagnostics and 4 mentions for CorVel. Quest Diagnostics' average media sentiment score of 0.99 beat CorVel's score of 0.46 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CorVel (CRVL) Competitors

$58.53 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$58.53 0.00 (0.00%)

As of 06/18/2026 05:27 PM Eastern

Compare

CRVL vs. CHE, MD, AMN, CCRN, and DGX

Should you buy CorVel stock or one of its competitors? MarketBeat compares CorVel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CorVel include Chemed (CHE), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Quest Diagnostics (DGX). These companies are all part of the "health care services" industry.

How does CorVel compare to Chemed?

CorVel (NASDAQ:CRVL) and Chemed (NYSE:CHE) are both mid-cap health care services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Chemed has a consensus target price of $501.50, indicating a potential upside of 14.80%. Given Chemed's stronger consensus rating and higher possible upside, analysts plainly believe Chemed is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

CorVel has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Chemed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

In the previous week, CorVel and CorVel both had 4 articles in the media. Chemed's average media sentiment score of 1.21 beat CorVel's score of 0.46 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemed	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.10	$110.34M	$2.14	27.35
Chemed	$2.54B	2.28	$265.24M	$18.35	23.81

51.4% of CorVel shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 44.6% of CorVel shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.23%. CorVel's return on equity of 29.92% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Chemed	10.23%	27.18%	17.38%

Summary

Chemed beats CorVel on 8 of the 15 factors compared between the two stocks.

How does CorVel compare to Pediatrix Medical Group?

Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 44.6% of CorVel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Pediatrix Medical Group has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.01	$165.39M	$2.06	11.47
CorVel	$958.53M	3.10	$110.34M	$2.14	27.35

CorVel has a net margin of 11.51% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 29.92% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	9.02%	19.94%	8.02%
CorVel	11.51%	29.92%	17.68%

In the previous week, CorVel had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Pediatrix Medical Group. CorVel's average media sentiment score of 0.46 beat Pediatrix Medical Group's score of 0.00 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pediatrix Medical Group presently has a consensus price target of $22.50, suggesting a potential downside of 4.75%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, research analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

CorVel beats Pediatrix Medical Group on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

AMN Healthcare Services has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

CorVel has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A
CorVel	$958.53M	3.10	$110.34M	$2.14	27.35

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by insiders. Comparatively, 44.6% of CorVel shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CorVel has a net margin of 11.51% compared to AMN Healthcare Services' net margin of -0.95%. CorVel's return on equity of 29.92% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	-0.95%	18.01%	5.19%
CorVel	11.51%	29.92%	17.68%

AMN Healthcare Services presently has a consensus target price of $25.29, suggesting a potential downside of 18.47%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, AMN Healthcare Services had 9 more articles in the media than CorVel. MarketBeat recorded 13 mentions for AMN Healthcare Services and 4 mentions for CorVel. CorVel's average media sentiment score of 0.46 beat AMN Healthcare Services' score of 0.42 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CorVel beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and CorVel (NASDAQ:CRVL) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

CorVel has a net margin of 11.51% compared to Cross Country Healthcare's net margin of -9.84%. CorVel's return on equity of 29.92% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cross Country Healthcare	-9.84%	-0.74%	-0.54%
CorVel	11.51%	29.92%	17.68%

Cross Country Healthcare currently has a consensus price target of $12.05, suggesting a potential downside of 8.50%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, equities analysts plainly believe Cross Country Healthcare is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, CorVel had 3 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Cross Country Healthcare. CorVel's average media sentiment score of 0.46 beat Cross Country Healthcare's score of 0.00 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cross Country Healthcare has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

CorVel has lower revenue, but higher earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A
CorVel	$958.53M	3.10	$110.34M	$2.14	27.35

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 44.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

CorVel beats Cross Country Healthcare on 11 of the 15 factors compared between the two stocks.

How does CorVel compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	1.95	$992M	$9.05	21.52
CorVel	$958.53M	3.10	$110.34M	$2.14	27.35

Quest Diagnostics currently has a consensus price target of $216.58, suggesting a potential upside of 11.19%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities analysts clearly believe Quest Diagnostics is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Quest Diagnostics has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by insiders. Comparatively, 44.6% of CorVel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CorVel has a net margin of 11.51% compared to Quest Diagnostics' net margin of 9.07%. CorVel's return on equity of 29.92% beat Quest Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.07%	15.60%	7.06%
CorVel	11.51%	29.92%	17.68%

In the previous week, Quest Diagnostics had 10 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Quest Diagnostics and 4 mentions for CorVel. Quest Diagnostics' average media sentiment score of 0.99 beat CorVel's score of 0.46 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Quest Diagnostics beats CorVel on 9 of the 16 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	BUSINESS SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$2.97B	$5.40B	$6.74B	$12.60B
Dividend Yield	N/A	2.89%	3.19%	5.81%
P/E Ratio	27.35	11.77	28.87	24.44
Price / Sales	3.10	1.40	381.30	110.16
Price / Cash	21.07	11.50	23.58	55.09
Price / Book	7.59	4.90	5.79	6.58
Net Income	$110.34M	$154.78M	$205.49M	$337.17M
7 Day Performance	-3.00%	-1.39%	6.14%	0.83%
1 Month Performance	-4.89%	12.37%	7.37%	2.25%
1 Year Performance	-42.68%	0.69%	35.64%	36.14%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.0065 of 5 stars	$58.53 flat	N/A	-42.7%	$2.97B	$958.53M	27.35	5,239	High Trading Volume
CHE Chemed	4.4694 of 5 stars	$430.17 +1.6%	$501.50 +16.6%	-20.1%	$5.71B	$2.53B	23.45	15,811	Positive News
MD Pediatrix Medical Group	1.5815 of 5 stars	$24.48 +0.5%	$22.50 -8.1%	+78.8%	$2.01B	$1.91B	11.89	4,315
AMN AMN Healthcare Services	1.7206 of 5 stars	$31.08 +0.6%	$25.29 -18.6%	+41.4%	$1.21B	$2.73B	N/A	2,664	News Coverage Analyst Upgrade Insider Trade Analyst Revision
CCRN Cross Country Healthcare	1.8833 of 5 stars	$13.19 +0.1%	$12.05 -8.6%	-6.1%	$426.27M	$1.05B	N/A	6,784	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and DGX

How does CorVel compare to Chemed?

Summary

How does CorVel compare to Pediatrix Medical Group?

Summary

How does CorVel compare to AMN Healthcare Services?

Summary

How does CorVel compare to Cross Country Healthcare?

Summary

How does CorVel compare to Quest Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and DGX

How does CorVel compare to Chemed?

Do analysts recommend CRVL or CHE?

Which has more risk & volatility, CRVL or CHE?

Does the media refer more to CRVL or CHE?

Which has stronger earnings & valuation, CRVL or CHE?

Do insiders & institutionals believe in CRVL or CHE?

Is CRVL or CHE more profitable?

Summary

How does CorVel compare to Pediatrix Medical Group?

Do insiders and institutionals have more ownership in MD or CRVL?

Which has more volatility and risk, MD or CRVL?

Which has higher earnings & valuation, MD or CRVL?

Is MD or CRVL more profitable?

Does the media prefer MD or CRVL?

Do analysts rate MD or CRVL?

Summary

How does CorVel compare to AMN Healthcare Services?

Which has more risk and volatility, AMN or CRVL?

Which has stronger valuation and earnings, AMN or CRVL?

Do institutionals & insiders have more ownership in AMN or CRVL?

Is AMN or CRVL more profitable?

Do analysts recommend AMN or CRVL?

Does the media favor AMN or CRVL?

Summary

How does CorVel compare to Cross Country Healthcare?

Is CCRN or CRVL more profitable?

Do analysts prefer CCRN or CRVL?

Does the media favor CCRN or CRVL?

Which has more volatility and risk, CCRN or CRVL?

Which has better earnings & valuation, CCRN or CRVL?

Do insiders & institutionals have more ownership in CCRN or CRVL?

Summary

How does CorVel compare to Quest Diagnostics?

Which has better valuation and earnings, DGX or CRVL?

Do analysts prefer DGX or CRVL?

Which has more risk and volatility, DGX or CRVL?

Do institutionals & insiders hold more shares of DGX or CRVL?

Is DGX or CRVL more profitable?

Does the media prefer DGX or CRVL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools